Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Stoke Therapeutics, Inc.

NASDAQ: STOK · Life Sciences · 6 alerts · CIK 1623526

Share price
$26.63Close, Nov 16
Market cap
$1.74B
Shares outstanding
65.41MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Stoke Therapeutics, Inc. filings on SEC EDGAR ↗

4:05 PM ET Form 4
Insider Selling

Stoke Therapeutics CMO Barry Ticho Sells $185K of Stock

Barry Ticho, CMO, sold 6,995 shares of Stoke Therapeutics, Inc. at $26.38 a share, worth $185K in total on Nov 2, 2026. Shares held after the trade: 12,064 (-36.7%).

Value
$185K
Shares
6,995
Price
$26.38
Role
CMO
Holding change
-36.7%
Trade date
Nov 2, 2026
5:37 PM ET Form 4
Insider Selling

Stoke Therapeutics General Counsel & Corp Sec Jonathan Allan Sells $16.5K of Stock

Jonathan Allan, General Counsel & Corp Sec, sold 627 shares of Stoke Therapeutics, Inc. at $26.33 a share, worth $16.5K in total on Oct 2, 2026. Shares held after the trade: 20,598 (-3.0%).

Value
$16.5K
Shares
627
Price
$26.33
Role
General Counsel & Corp Sec
Holding change
-3.0%
Trade date
Oct 2, 2026
5:36 PM ET Form 4
Insider Selling

Stoke Therapeutics CMO Barry Ticho Sells $27.5K of Stock

Barry Ticho, CMO, sold 1,051 shares of Stoke Therapeutics, Inc. at $26.16 a share, worth $27.5K in total on Oct 1, 2026. Shares held after the trade: 19,059 (-5.2%).

Value
$27.5K
Shares
1,051
Price
$26.16
Role
CMO
Holding change
-5.2%
Trade date
Oct 1, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.